Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: Results from a large population-based study of the Italian Society for Rheumatology

RMD Open

Volumn 3, Issue 2, 2017, Pages

  Caprioli, Marta ^a   Carrara, Greta ^b   Sakellariou, Garifallia ^c   Silvagni, Ettore ^d   Scirè, Carlo Alberto ^b,d  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Epidemiology Unit   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Aromatase inhibitors; Breast cancer; Rheumatoid arthritis; Tamoxifene

Indexed keywords

ANASTROZOLE; EXEMESTANE; LETROZOLE; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HUMAN; ICD-9; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; POPULATION RESEARCH; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TREATMENT DURATION;

EID: 85030547727     PISSN: None     EISSN: 20565933     Source Type: Journal    
DOI: 10.1136/rmdopen-2017-000523     Document Type: Article

References (19)

1. Shanmugam VK, McCloskey J, Elston B, et al. The CIRAS study: a case control study to defne the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms. Breast Cancer Res Treat 2012;131:699-708.
2. Niravath P. Aromatase inhibitor-induced arthralgia: a review. Ann Oncol 2013;24:1443-9.
3. Din OS, Dodwell D, Wakefeld RJ, et al. Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we fnd out more? Breast Cancer Res Treat 2010;120:525-38.
4. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
5. Singer O, Cigler T, Moore AB, et al. Defning the aromatase inhibitor musculoskeletal syndrome: a prospective study. Arthritis Care Res 2012;64:1910-8.
6. Laroche M, Borg S, Lassoued S, et al. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome. J Rheumatol 2007;34:2259-63.
7. Guidelli GM, Martellucci I, Galeazzi M, et al. Sjögren's syndrome and aromatase inhibitors treatment: is there a link? Clin Exp Rheumatol 2013;31:653-4.
8. Wendling D, Letho-Gyselinck H, Guillot X, et al. Arthralgia and aromatase inhibitors. Joint Bone Spine 2014;81:187-8.
9. Bertolini E, Letho-Gyselinck H, Prati C, et al. Rheumatoid arthritis and aromatase inhibitors. Joint Bone Spine 2011;78:62-4.
10. Morel B, Marotte H, Miossec P. Will steroidal aromatase inhibitors induce rheumatoid arthritis? Ann Rheum Dis 2007;66:557-8.
11. Creamer P, Lim K, George E, et al. Acute infammatory polyarthritis in association with tamoxifen. Br J Rheumatol 1994;33:583-5.
12. Richards AJ. Acute infammatory polyarthritis in association with tamoxifen. Br J Rheumatol 1994;33:998.
13. Chao J, Parker BA, Zvaifer NJ. Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis. J Rheumatol 2009;36:1087-8.
14. Chen JY, Ballou S P. The effect of antiestrogen agents on risk of autoimmune disorders in patients with breast cancer. J Rheumatol 2015;42:55-9.
15. Alpízar-Rodríguez D, Pluchino N, Canny G, et al. The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology 2017;56:1254-63.
16. Capellino S, Straub RH, Cutolo M. Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue infammation: common pathway in both sexes. Ann N Y Acad Sci 2014;1317:24-31.
17. Carrara G, Scirè CA, Zambon A, et al. A validation study of a new classifcation algorithm to identify rheumatoid arthritis using administrative health databases: case-control and cohort diagnostic accuracy studies. results from the RECord linkage on rheumatic diseases study of the Italian society for rheumatology. BMJ Open 2015;5:e006029.
18. Bunn A, Korpela M. Team RC others. R: a language and environment for statistical computing. 2013 http://cran.focruz.br/web/packages/dplR/vignettes/timeseries-dplR.pdf (accessed 1 Oct 2016).
19. Wang J, Zhang Q, Jin S, et al. Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis. Exp Gerontol 2009;44:398-405.